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The molecular conformation of achatin-I neutral form (H-Gly-D-Phe-Ala-Asp-OH), an endogenous neuropeptide, was elucidated by X-ray crystal 
analysis. The molecule has a type II’ B-turn structure with the D-Phe-Ala residues at the corner of the bend, which is further stabilized by two 
NH(Gly)...Cy=06(Asp) and NH(Asp)...CY=06(Asp) intramolecular hydrogen bonds. This turn conformation may be an important feature of 
achatin-I related to its neuroexcitatory activity. 
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1. INTRODUCTION 
Recently a neuroexcitatory tetrapeptide termed as 
achatin-I was isolated from the ganglia of an African 
giant snail (Achatina fulica Ferussac) [l]. Achatin-I 
consists of H-Gly-D-Phe-Ala-Asp-OH and is the first 
example of the endogenous neuropeptide having a D- 
amino acid residue. 
Achatin-I induces a voltage-dependent inward cur- 
rent due to sodium ions on the identifiable neurons 
[ 1,2], and is likely to play an important role as an ex- 
citatory neurotransmitter in the heart regulation of A. 
fulica [3]. The neuroactivity of achatin-I is 
stereospecific, and no other stereoisomers which are 
replaced with L- or D-amino acid residues show such a 
biological effect [1,2]. This means that a strict 
stereospecificity is required for the interaction with the 
receptor on Achatina neurons. 
The elucidation of the three-dimensional structure of 
the bioactive molecule is important for the understan- 
ding of structure-activity relationships and the 
substrate-specificity of the receptor. The study of the 
stable conformation of achatin-I would further provide 
a reason why the D-configuration of Phe at the second 
position is necessary for the activity. In this paper we 
report the conformational characteristics of the 
achatin-I-free form, based on its X-ray crystal analysis. 
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2. EXPERIMENTAL 
Achatin-I was synthesized with the conventional solid-phase 
method, and purified by gel filtration (Sephadex G-10) and reversed- 
phase HPLC. Many attempts to crystallize the molecule finally led to 
transparent needle crystals, which were grown from the 
methanolJdioxane mixture by slow evaporation in ‘the open at- 
mosphere at room temperature. Crystal data are as follows: 
CisHz4N407, M,= 408.41, monoclinic, space group J??.i, a= 5.083 (l), 
b=9.125(1),~=20.939(3)A,P=94.73(1)”, V=967,9(3)A’,Z=2, 
D,,,= 1.400 (3) g. cmW3, D,= 1.401 g. cmm3 and p (Cu Ko)=9.77 
cm-‘. 
A total of 1748 intensity data (205 130”) were collected on a Rigaku 
AFC-5 diffractometer with graphite-monochromated Cu Ka radia- 
tion using w-20 scan technique (resolution = 0.85 A), and were cor- 
rected for the usual Lorentz and polarization effects. The crystal 
structure was solved by the direct method with a program 
MULTAN87 [4]. The refinement of non-hydrogen atoms with 
anisotropic thermal parameters and of hydrogen atoms with isotropic 
ones converged to the discrepancy R and R, values of 0.051 and 
0.072, respectively. The crystallographic details will be reported 
elsewhere, and atomic coordinates at this stage are available from one 
of authors (T.I.) on request. 
3. RESULTS AND DISCUSSION 
A stereoscopic view of achatin-I molecular confor- 
mation is shown in Fig. 1. The conformational torsion 
angles are given in Table I. No noticeable abnormality 
was observed for the bond lengths and angles, and the 
side chains of the Phe and Asp residues also belong to 
one of the most frequently observed conformations in 
peptides and proteins [5,6]. Two C-O bond lengths of 
the Asp a-carboxyl group are significantly different 
from each other (1.205 (5) and 1.312 (5) A), while those 
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Fig. 1. Stereoscopic view of achatin-I. Thin lines represent possible intramolecular hydrogen bonds. 
of the Asp @-carboxyI group are almost the same (1.233 
(5) and 1.265 (5) A}. The amino terminal of the GIy 
residue, on the other hand, participates in the forma- 
tion of an intramolecular and 2-3 intermolecular 
hydrogen bonds. Although hydrogen atoms could not 
be clearly observed on the electron density map, such 
bond lengths and hydrogen bonding mode indicate that 
the molecule exists as a zwitterion with the N-terminal 
end protonated and the carboxyl of the Asp side chain 
deprotonated; the C-terminal is in a neutral state. 
As a whole, achatin-I adopts a turn conformation 
stabilized by two intramolecular hydrogen bonds of 
NH(Gly)...CY=O*(Asp) (2.816 (5) A) and 
NH(Asp)...C?= O”(Asp) (2.950 (5) A). Although an in- 
tramolecular hydrogen bond is not directly formed be- 
tween the C= O(Gly) and NH(Asp) groups, the 
molecule shows a type II ’ p-turn structure with the D- 
Phe-Ala residues at the corner of the bend. A similar 
conformation has also been observed in D-Phe-Ala 
residues of cyclo(Gly-Pro-D-Phe-Ala-Pro) 1711 
although the chemical structures are largely different 
from each other. Thus, this turn conformation cor- 
responds to a favored conformation for the peptide 
having D-L residues in positions i+ 1 and i+ 2 of the 
turn [8]. Further the Gly-D-Phe-Ala fragment shows 
the characteristic of the y-turn conformation, and a 
weak interaction is observed between the NH(Ala) and 
C=O(Gly) groups [N...O=3.689 (5) A]. 
Table I 
Conformational angles of achatin-I 
GlY D-Phe Ala Asp 
(0 - 95.2 (3) -138.3 (4) -111.2 (4) 
$ 157.8 (4) -111.7 (4) 37.1 (4) -170.9 (3) 
w -172.0 (4) -175.4 (4) -171.3 (4) - 
Xl - -179.2 (4) - 76.4 (3) 
x2 - 89.9 (5) - -37.7 (4) 
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A significant characteristic of achatin-I conforma- 
tion is the participation of the Asp p-carboxyl O* atom 
in two intramolecular hydrogen bonds, thus forming a 
plane consisting of the Gly-D-Phe-Ala backbone and 
Asp side chains. This conformation appears to be stable 
and mostly exists in the solution state; a similar turn 
conformation has also been derived from the NMR 
conformationa~ analyses (Iwashita et al., unpublished~. 
A small peptide that elicits a particular biological 
response must maintain a suitable orientation of bin- 
ding groups for productive interaction with a receptor. 
A turn conformation observed, which is stabilized by 
the P- and/or y-turn structure and the intramolecular 
hydrogen bonds, guarantees the proper arrangement of 
groups essential for receptor binding. The backbone 
conformation itself may not be essential to the activity 
of achatin-I. Instead, optimal placement of D-Phe, Ala 
and Asp side chains seems to be the requirement for its 
bioactivity. The replacement of D-Phe with L-Phe 
would cause severe steric hindrance between the Phe 
benzene ring and the backbone chain, and thus lead to 
another type of molecular conformation which is 
significantly different from the present conformation 
of achatin-I. Similar steric effects could also be accom- 
panied by the configurational change of Ala and Asp 
residues. The detailed ~onformational analyses of all 
achatin stereoisomers would make the active conforma- 
tion of achatin-I more clear. 
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